Safety and Efficacy of Recombinant Botulinum Toxin Type A for Moderate-to-severe Glabellar Lines: A Multicenter Randomized Controlled Trial
1. 系统已在2026-03-16 12:31:20对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1097/PRS.0000000000012960
文献链接: https://journals.lww.com/10.1097/PRS.0000000000012960
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Qingfeng Li; Xiao Long; Chongyuan Xu; Zhiqi Hu; Yun Xie; Nanze Yu; Ping Jiang; Wu Yang; Xiaoyun Sun

